Is women's health high yield on the PEBC exam?

Yes, especially contraception, which is one of the most practical areas for a community pharmacist. Menopause, pregnancy and breastfeeding safety, and vaginitis also come up. The exact mix is randomized from one sitting to the next, but contraception is consistently worth strong preparation.

What women's health topics should I focus on for the PEBC?

Focus on contraception (method selection, the estrogen contraindications, missed-pill rules, and emergency contraception), menopause and hormone therapy, pregnancy and breastfeeding drug safety, and vaginitis. Matching the option to the patient's contraindications matters more than memorizing every product.

Which guidelines should I use for women's health on the PEBC?

The Canadian standard references are the SOGC guidelines (the Society of Obstetricians and Gynaecologists of Canada) for contraception and menopause. The PEBC expects the Canadian approach, so study from SOGC rather than from a US source.

How should I study women's health for the PEBC?

Learn the estrogen contraindications cold, know the missed-pill and emergency contraception rules, and get comfortable checking pregnancy and breastfeeding drug safety. Then read each vignette for the patient factor that changes the answer.

PEBC Women's Health Practice Questions

Women's health is a high-yield, very practical area on the PEBC exam, and contraception is the heart of it. Method selection, contraindications, missed-pill rules, emergency contraception, menopause, and pregnancy safety all show up, and most questions come down to matching the right option to a specific patient.

The questions below are a sample, weighted toward contraception with a vaginitis case. Each explanation argues every option, right and wrong, down to the contraindication or patient factor that tips the answer.

Independent PEBC-style practice, grounded in Canadian references and not official PEBC exam content.

Official PEBC exam overview PEBC references and resources

free questions here

no signup to start

All 4

options explained

full clinical case

How to approach a PEBC women's health question

1For contraception, read the patient for the contraindication that rules out estrogen: smoking over age 35, migraine with aura, a VTE history, or active breastfeeding in the early postpartum period.
2Know the missed-pill rules and the emergency contraception options, including the timing window for each.
3For pregnancy and breastfeeding, check each drug for safety rather than guessing, and default to the agents with the best safety data.
4Anchor on the SOGC guidelines (the Society of Obstetricians and Gynaecologists of Canada), the Canadian standard for contraception and menopause.
5Watch for the drug interactions that reduce contraceptive efficacy, especially enzyme inducers.

Practice questions

Tap an answer to see why each option is right or wrong.

Question 1Contraception

DK is a 35-year-old female (G1P1) who had a copper IUD (Flexi-T) inserted 4 months ago. She takes lisinopril 10 mg daily for hypertension. She presents reporting significantly heavier and more painful periods since insertion. Her hemoglobin is 118 g/L. She is satisfied with the method and wants to continue hormone-free contraception. What is the MOST appropriate recommendation?

Incorrect · Answer: C

PEBC Yield: Hightreatment-failureadverse-effectsdrug-selection

Tranexamic acid reduces heavy menstrual bleeding but does not address the painful cramping she reports. An NSAID addresses both symptoms simultaneously.

Tempting because the levonorgestrel IUS dramatically reduces menstrual flow (90% reduction). However, she specifically wants hormone-free contraception and is satisfied with her copper IUD. Switching to a hormonal method contradicts her preference.

C) (Correct)

Correct -- NSAIDs like ibuprofen reduce prostaglandin-mediated cramping and can decrease menstrual flow. Heavy/painful periods are the most common copper IUD side effect and leading reason for discontinuation. Symptomatic management allows her to maintain her preferred hormone-free method.

Removing the IUD abandons her preferred hormone-free LARC. Condoms have much higher typical-use failure rates (18%). This is premature before attempting symptomatic management.

Question 2Contraception

VT is a 32-year-old female starting Yasmin (drospirenone/EE 30 mcg) for contraception and acne management. Current medications include lisinopril 10 mg daily and potassium chloride 20 mEq daily for documented hypokalemia. Most recent K+ is 4.2 mmol/L, SCr 78 umol/L. Hemoglobin is 132 g/L and platelets are normal. Which drug therapy problem should the pharmacist prioritize?

Incorrect · Answer: B

PEBC Yield: Highdrospirenonehyperkalemiadrug interaction

While potassium supplementation alongside drospirenone warrants monitoring, this patient has documented hypokalemia requiring supplementation. The more critical interaction is the dual potassium-raising effect of drospirenone plus lisinopril.

B) (Correct)

Correct. Drospirenone has anti-mineralocorticoid properties that increase serum potassium. Combined with lisinopril, which independently raises potassium via RAAS inhibition, there is a clinically significant hyperkalemia risk. Monitor serum potassium in patients on an ACE inhibitor or ARB who start a drospirenone-containing COC.

ACE inhibitors are not contraindicated with COCs as a class. The specific concern is only with drospirenone-containing COCs due to the additive potassium-sparing effect. This answer overgeneralizes the interaction.

EE 30 mcg is a standard-dose formulation and is appropriate for acne management. Low-dose formulations (20-25 mcg) also exist but 30 mcg is not subtherapeutic. This would be correct if the dose were below 20 mcg.

Question 3Contraception

NP is a 19-year-old female with moderate acne and hirsutism who requests an oral contraceptive. PMHx includes seasonal allergic rhinitis treated with cetirizine. She has no history of VTE, migraine, or liver disease. BMI is 23, BP 118/72 mmHg, SCr 62 umol/L. Which progestin component would be MOST appropriate?

Incorrect · Answer: D

PEBC Yield: Highprogestin generationsandrogenic activityCOC selection

Norethindrone is a first-generation progestin rated ++ for androgenic activity. While less androgenic than levonorgestrel, it does not provide the anti-androgenic benefit this patient requires. It would be reasonable when mild progestogenic effect is desired.

Desogestrel is a third-generation progestin rated ++ for androgenic activity. It has reduced androgenicity compared to second generation but lacks the direct anti-androgenic properties of drospirenone that this patient needs.

Levonorgestrel is a second-generation progestin rated ++++ for androgenic activity. It would likely worsen acne and hirsutism rather than improve them. It would be appropriate when anti-androgenic effects are not needed and lower VTE risk is prioritized.

D) (Correct)

Correct. Drospirenone is a fourth-generation progestin with anti-androgenic properties that actively opposes androgen effects. It is the best choice for a patient with acne and hirsutism. Her normal renal function and absence of ACE-I/ARB use means no hyperkalemia concern.

Question 4Reproductive Health

D.W. is a 29-year-old breastfeeding female who had unprotected intercourse 4 days ago. She is 8 weeks postpartum, exclusively breastfeeding, and amenorrheic. She requests emergency contraception. Which of the following statements about her emergency contraception options is FALSE?

Incorrect · Answer: D

PEBC Yield: Low-Medcounsellingcontraindication-check

This statement is true. Ulipristal acetate (Ella) 30 mg single dose is effective within 5 days of unprotected intercourse and is more effective than levonorgestrel near the time of ovulation due to its selective progesterone receptor modulation.

This statement is true. Ulipristal acetate requires the breastfeeding mother to pump and discard breast milk for one week after use due to drug transfer into breast milk.

This statement is true. Levonorgestrel (Plan B) 1.5 mg single dose is effective within 72 hours of unprotected intercourse. No breastfeeding interruption is required, making it convenient for breastfeeding mothers.

D) (Correct)

This statement is FALSE. Lactational amenorrhea is effective only when ALL three criteria are met: less than 6 months postpartum, exclusively breastfeeding with greater than 75% of feedings, AND amenorrheic. It is NOT reliable for 12 months and is not recommended as a sole contraceptive method even when all criteria are met.

Question 5Reproductive Health

S.T. is a 34-year-old female who is 10 weeks pregnant with type 2 diabetes managed with metformin 1000 mg BID. Her maternal aunt had a child with a neural tube defect. She asks about folic acid supplementation. Which of the following is the most appropriate folic acid regimen?

Incorrect · Answer: B

PEBC Yield: Low-Meddrug-selectiondose-adjustment

A dose of 0.4 mg daily is appropriate only for low-risk patients with no family history of NTD and no folate-inhibiting medications. S.T. has both diabetes and metformin use (a folate-inhibiting drug), plus a non-immediate family history of NTD, placing her at moderate risk.

B) (Correct)

Correct -- S.T. has multiple moderate-risk factors: maternal diabetes, metformin use (a folate-inhibiting medication), and a non-immediate family history of NTD (maternal aunt's child). Moderate risk requires 1 mg daily preconception through 12 weeks, then stepping down to 0.4 mg daily.

This dose is reserved for high-risk patients and would not be continued at full dose throughout the entire pregnancy. After 12 weeks, all risk categories step down to 0.4 mg daily regardless of initial risk level.

A dose of 4-5 mg daily is reserved for high-risk patients: those with a personal history of NTD, previous NTD pregnancy, or a first-degree relative with NTD. S.T.'s aunt is not a first-degree relative, so she does not meet high-risk criteria.

Question 6Drugs in Pregnancy and Lactation

Which possible teratogen has small-study cleft lip or palate concern not confirmed by larger studies?

Incorrect · Answer: A

PEBC Yield: Highcontraindication-checkevidence-appraisal

A) (Correct)

Correct. Diazepam had small-study cleft lip/palate concern, but larger studies did not confirm a strong signal.

Methimazole is the scalp-defect/embryopathy discussion, not the diazepam cleft-lip question.

Fingolimod has pregnancy-avoidance concerns, but it is not the small-study cleft-lip example here.

Fluconazole pregnancy concern depends on dose and indication; it is not the diazepam small-study cleft signal.

Question 7Medical Abortion

RS is a 33-year-old female who completed medical abortion with Mifegymiso 4 days ago. She presents to the emergency department with swelling, heart rate of 118 bpm, diffuse abdominal pain, and flu-like symptoms. Her temperature is 36.8 degrees Celsius. Which of the following statements about this presentation is FALSE?

Incorrect · Answer: C

PEBC Yield: LowADR-recognitionurgency-referral

This is a TRUE statement. TSS requires emergent empiric broad-spectrum antibiotics as part of initial management. Delay in antibiotic therapy increases mortality risk.

This is a TRUE statement. Toxic shock syndrome (TSS) following medical abortion classically presents WITHOUT fever, which distinguishes it from other infections. The combination of tachycardia, swelling, and flu-like symptoms without fever is characteristic.

C) (Correct)

This is the FALSE statement -- prophylactic antibiotics are NOT recommended in medical abortion. Infection rates with medical abortion are very low, and prophylactic antibiotics have not been shown to prevent TSS. This is unlike surgical abortion where prophylaxis may be considered.

This is a TRUE statement. In severe or refractory TSS, surgical debridement and in extreme cases hysterectomy may be required as part of definitive management.

Question 8Women's Health

KL is a 32-year-old female who presents to your pharmacy complaining of irritability, bloating, breast tenderness, and depressed mood that have been recurring monthly for the past 6 months. She tracks her symptoms with a daily diary and notes they consistently begin 8 days before menses and resolve within 2 days of onset. She has no history of psychiatric illness and is not seeking contraception. She has tried lifestyle modifications including exercise and dietary changes for 3 months without adequate relief. Which of the following is the most appropriate pharmacological recommendation?

Incorrect · Answer: D

PEBC Yield: Low-Meddrug-selectioncounselling

GnRH agonists such as leuprolide are last-line therapy reserved for severe PMS/PMDD refractory to both COCs and SSRIs. They carry serious adverse effects including decreased bone mineral density, metabolic and cardiovascular effects, and psychiatric events. Initiating leuprolide before trying SSRIs or COCs is premature.

NSAIDs like naproxen are appropriate for physical symptoms of PMS such as headache, breast pain, and myalgia. However, KL's predominant complaints are mood-related (irritability, depressed mood), for which NSAIDs are not effective.

COCs containing drospirenone are effective for moderate-to-severe PMS, but are reserved for patients who also require contraception. KL is not seeking contraception, making an SSRI the preferred first-line pharmacological option for mood-dominant symptoms.

D) (Correct)

Correct -- SSRIs are first-line pharmacotherapy for PMS with predominant mood symptoms in women not requiring contraception. Luteal-phase dosing (days 14 to onset of menses) is effective and reduces cumulative drug exposure compared to continuous dosing. KL has confirmed luteal-phase symptom confinement over multiple cycles and failed non-pharmacological measures.

Question 9Menopause

AH is a 52-year-old female who has been postmenopausal for 1 year. She has moderate-severe vasomotor symptoms and an intact uterus. She has elevated triglycerides (4.2 mmol/L), frequent migraines with aura, and a BMI of 22. She has no history of VTE or breast cancer. Which of the following is the most appropriate hormone therapy formulation for AH?

Incorrect · Answer: A

PEBC Yield: Low-Meddrug-selectionintraclass-differentiationcontraindication-check

A) (Correct)

Correct -- transdermal estradiol bypasses first-pass hepatic metabolism and does not elevate triglycerides, making it the preferred route for patients with hypertriglyceridemia. It is also preferred in patients with migraines. AH is within 10 years of menopause onset with no contraindications to transdermal estrogen. Progesterone is required because she has an intact uterus. Micronized progesterone is preferred over MPA for its better cardiovascular and breast safety profile.

Gabapentin is a non-hormonal alternative for patients with contraindications to all forms of hormone therapy. AH has elevated triglycerides and migraines, which are reasons to avoid oral estrogen specifically, but transdermal estrogen remains appropriate. Defaulting to a less effective non-hormonal agent when a safe hormonal option exists is suboptimal.

Oral estrogen undergoes first-pass hepatic metabolism and further elevates triglycerides. In AH, who already has significantly elevated triglycerides at 4.2 mmol/L, oral estrogen could precipitate pancreatitis. Oral estrogen is also less preferred in patients with migraines due to higher thromboembolic risk.

TSEC is an oral formulation. Like other oral estrogen products, it undergoes first-pass hepatic metabolism and would exacerbate AH's elevated triglycerides. The transdermal route is specifically indicated to avoid hepatic first-pass effects in this clinical scenario.

Question 10Menopause

RG is a 63-year-old female who presents to the pharmacy requesting hormone therapy for hot flashes that started approximately 2 years ago. She reports her last menstrual period was at age 50. She has hypertension controlled on amlodipine 5 mg daily, type 2 diabetes on metformin 1000 mg twice daily, and a BMI of 31. She has no history of VTE or breast cancer. Which of the following statements is NOT correct regarding hormone therapy initiation in RG?

Incorrect · Answer: A

PEBC Yield: Low-Medcontraindication-checkdrug-selectioncounselling

A) (Correct)

This statement is NOT correct. There is no absolute age cutoff for hormone therapy. SOGC guidelines state that initiation beyond age 60 or more than 10 years after menopause carries higher risk, but it is not absolutely contraindicated. The decision requires individualized risk-benefit assessment. Furthermore, women already on hormone therapy may continue beyond age 65 if benefits outweigh risks.

This statement is correct. Given that RG is beyond the safe window for hormone therapy initiation and has multiple cardiovascular risk factors (hypertension, diabetes, obesity), non-hormonal alternatives like venlafaxine are the more appropriate first-line approach for her vasomotor symptoms.

This statement is correct. The timing hypothesis states that hormone therapy is safest when initiated within 10 years of menopause onset or before age 60. RG's menopause onset was at age 50 and she is now 63, meaning 13 years have elapsed since menopause -- well beyond the 10-year safe window. Late initiation carries higher cardiovascular and thromboembolic risk.

This statement is correct. If hormone therapy were considered despite the late initiation, transdermal estrogen would be preferred because it bypasses first-pass hepatic metabolism, has lower VTE risk, does not worsen triglycerides, and is preferred in obese patients (BMI 31).

Want the full bank?

These are a sample. The full bank adds full-length cases and timed mock exams.

Sample full case

One patient with several linked questions, the format the real exam uses for case clusters.

DM is a 31-year-old G2P1 woman at 24 weeks' gestation who presents to your community pharmacy with vulvovaginal itching and irritation that began 3 days ago. She is otherwise healthy aside from gestational diabetes diagnosed 4 weeks ago. She has no fever, no abdominal pain, no abnormal vaginal bleeding, and no contractions.

Item	Detail
PMHx	Gestational diabetes (well-controlled by diet so far); seasonal allergies
Medications	Prenatal multivitamin with folic acid 1 mg PO daily; Diclectin 10 mg/10 mg PO 2 tabs at bedtime PRN nausea
Allergies	NKDA
Recent self-care	Daily perfumed panty-liner; one over-the-counter scented vaginal wash twice over the past week
Vitals	BP 118/74; HR 82; T 36.8 °C

She asks if you can recommend something OTC.

Question 1Vaginitis

Which of the following is the LEAST helpful first question to ask DM in triaging her symptoms today?

Incorrect · Answer: D

PEBC Yield: Low-Medscreeningcounsellingdiagnosis-classification

Glycemic status is a relevant background risk factor for recurrent vulvovaginal candidiasis in a woman with gestational diabetes, and asking about it is reasonable as a follow-up question once the type of vaginitis is established. It is more clinically useful than asking about laundry detergent and therefore is not the LEAST helpful first question. Would be reframed as the leading question only if recurrent candidiasis were already confirmed.

Asking about the character of vaginal discharge is the highest-yield first question because it differentiates the vaginitis triad: white clumpy/cottage-cheese with itching points to candidiasis, thin grey-white with fishy odour points to BV, and frothy yellow-green with itching points to trichomoniasis. In pregnancy, BV and trichomoniasis must be treated to reduce risk of preterm birth, while uncomplicated candidiasis can be self-treated topically. This is the MOST helpful first question, not the least helpful.

Symptom duration matters for chronicity and refer thresholds, and it has already been partially provided in the workflow. It is more useful than the contact-dermatitis screen and therefore is not the LEAST helpful first question.

D) (Correct)

Correct. Contact dermatitis from new soaps, detergents, or wipes is a much less common cause of vulvovaginal symptoms in a pregnant patient than infectious vaginitis, and asking about it first delays the differential that would actually change pregnancy management. Asking about discharge character, glucose, and duration are all higher-yield triage questions in this workflow. Would be appropriate to ask later only if the vaginitis triad has been ruled out and irritant or allergic contact dermatitis becomes the leading hypothesis.

Question 2Vaginitis

DM tells you the discharge is thin, grey-white, and has a strong fishy odour, especially after intercourse. Which factor in DM's history MOST increases her risk of this presentation?

Incorrect · Answer: A

PEBC Yield: Low-Medscreeningnon-pharmacologicalcounselling

A) (Correct)

Correct. Vaginal douching and the use of scented vaginal washes disrupt the normal lactobacillus-dominant vaginal flora, raise vaginal pH, and allow overgrowth of anaerobes such as Gardnerella vaginalis — the hallmark of bacterial vaginosis. Counselling pregnant patients to stop douching and stop scented intravaginal products is a guideline-supported, modifiable intervention. Would be incorrect if the discharge profile fit candidiasis or trichomoniasis instead.

Diabetes (including gestational) is the classic risk factor for recurrent vulvovaginal candidiasis because elevated glucose supports yeast overgrowth, but DM's discharge profile is consistent with bacterial vaginosis rather than candidiasis. Would be the best answer if her discharge were thick, white, and curd-like with itching.

Perfumed liners can irritate the vulvar skin and can act as a co-trigger for symptomatic candidiasis or contact dermatitis, but they are not the dominant risk factor for the bacterial vaginosis pattern she is describing. Would be appropriate to counsel her to discontinue these as a general hygiene step, but they are not the primary risk lever here.

A standard prenatal multivitamin has no plausible mechanism for triggering bacterial vaginosis. Iron and folic acid intake do not alter vaginal flora. Would be incorrect in any vaginitis scenario.

Question 3Vaginitis

DM's nurse-midwife confirms bacterial vaginosis on a wet mount with clue cells. DM does not want to apply anything intravaginally during pregnancy. Which of the following is the MOST appropriate treatment?

Incorrect · Answer: D

PEBC Yield: Low-Meddrug-selectioncounsellingduration-of-therapy

Fluconazole treats vulvovaginal candidiasis, not bacterial vaginosis. It has no activity against the anaerobic overgrowth driving BV and is also generally avoided in pregnancy because of teratogenicity at higher doses. Would be incorrect for any presentation of BV.

Topical metronidazole gel has equivalent cure rates to oral therapy and is acceptable in pregnancy, but it is intravaginal — directly contrary to DM's stated preference. Choosing it overrides her informed preference when an equally effective oral option exists. Would be appropriate if she were comfortable with topical therapy and tolerating oral metronidazole was a problem.

Topical clindamycin is an alternative for BV but is also intravaginal, and it contains mineral oil which decreases the effectiveness of latex condoms and diaphragms — relevant counselling even in pregnancy. It is therefore both contrary to her preference and a less convenient choice in this scenario. Would be appropriate if metronidazole were contraindicated and she preferred topical therapy.

D) (Correct)

Correct. Oral metronidazole 500 mg BID for 7 days is a first-line regimen for bacterial vaginosis, has equivalent cure rates to topical metronidazole, and is the only listed option that respects DM's preference to avoid intravaginal therapy. Treating BV in pregnancy is not optional — untreated BV increases the risk of preterm rupture of membranes, preterm labour, preterm birth, and postpartum endometritis. Counsel her to avoid alcohol during therapy and for 24–48 hours after the last dose because of the disulfiram-like reaction. Would be incorrect in a non-pregnant patient who preferred topical therapy or was unable to tolerate oral metronidazole.

Full-length cases like this, across every PEBC domain, live in the question bank.

Frequently asked questions

Is women's health high yield on the PEBC exam?: Yes, especially contraception, which is one of the most practical areas for a community pharmacist. Menopause, pregnancy and breastfeeding safety, and vaginitis also come up. The exact mix is randomized from one sitting to the next, but contraception is consistently worth strong preparation.
What women's health topics should I focus on for the PEBC?: Focus on contraception (method selection, the estrogen contraindications, missed-pill rules, and emergency contraception), menopause and hormone therapy, pregnancy and breastfeeding drug safety, and vaginitis. Matching the option to the patient's contraindications matters more than memorizing every product.
Which guidelines should I use for women's health on the PEBC?: The Canadian standard references are the SOGC guidelines (the Society of Obstetricians and Gynaecologists of Canada) for contraception and menopause. The PEBC expects the Canadian approach, so study from SOGC rather than from a US source.
How should I study women's health for the PEBC?: Learn the estrogen contraindications cold, know the missed-pill and emergency contraception rules, and get comfortable checking pregnancy and breastfeeding drug safety. Then read each vignette for the patient factor that changes the answer.